Human CD86/B7-2 quantitates human CD86/B7-2 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD86/B7-2.
Human CD86/B7-2 quantitates human CD86/B7-2 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD86/B7-2.
The CD86 protein is one of two ligands (the other CD80) for CTLA4 and CD28. The CD86 protein acts as a costimulation molecule by obtaining the help of T cells during the presentation of antigen. The presentation of antigen in the absence of sufficient costing involving a CD86/CD80 protein may lead to tolerance. CD80 protein appears to play a distinct role from CD80 protein in the differentiation of auxiliary T cells. CD86 protein is a Type I membrane protein that is part of the immunoglobulin superfamily. CD86 protein is expressed by antigen cells and is the ligand of two proteins at the cell surface of T cells, CD28 antigen and the protein associated with cytotoxic T lymphocyte 4. The binding of CD86 to CD28 antigen is a costimulation signal for T cell activation. The binding of the CD86 protein to the protein associated with cytotoxic T-lymphocyte 4 negatively regulates T-cell activation and decreases the immune response. The alternative splicing results in two transcription variants that encode different isoforms of CD86. Other transcription variants were described for CD86, but their total length sequences were not determined. Diseases associated with CD86 protein dysfunction include epidermoid carcinoma of the gallbladder and myocarditis.
Sensitivity
Sensitivity of dosage: 0.82 ng/ml.
Measurement range
Dosing range: 0.82 to 200 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17105339 |
| Specifications |
| Accession number | Antigen of activation B7-2; B7; B7.2; B70; B7-2; lymphocyte activation antigen B7-2; BU63; Cd28l2; CD28LG2; CD86; CD86 antigen; CD86 antigen (ligand antigen CD28 2, antigen B7-2); CD86 antigen precursor; CD86 molecule; CLS1; counter-receptor CTLA-4 B7.2; molecule-1 |
| Dose range | 0.82 to 200 ng/ml |
| Sensitivity of the dosage | 0.82 ng/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | P42081 |
| Gene symbol(s) | CD86 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | Use exclusively for research |
| Target | CD86 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Serum, 50 µl; plasma, 50 µl; supernatant, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EH99RBX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.